We are pleased to announce our Application Review Committee, which is comprised of board members, past grant recipients, and respected members of the Psychedelic Science community.
Degree: Ph.D. Biomedical Sciences (Pharmacology & Neuroscience)
I am highly interested in the behavioral pharmacology of classic psychedelics, such as LSD, psilocybin, and DMT, and putative entactogens, such as MDMA and methylone, in terms of both therapeutic potential and consequences of misuse.
Research Gate Profile: https://www.researchgate.net/profile/Sean_Dolan3
Psychologist Rachel Harris, PhD is the author of Listening to Ayahuasca: New Hope for Depression, Addiction, PTSD and Anxiety. She was in private practice for thirty-five years working with people interested in psychospiritual development. During a decade working in research, Rachel received a National Institutes of Health New Investigator’s Award and published more than forty scientific studies in peer-reviewed journals. She has also consulted to Fortune 500 companies and the United Nations.
Rachel was in the 1968 Esalen Residential Program, Big Sur, CA. This intensive six-month program focused on meditation and body work. In the early seventies, Rachel studied with Dorothy Nolte in the movement system, Structural Awareness, based on Dr. Ida Rolf’s Structural Integration (Rolfing). Rachel also co-edited the Journal of the American Dance Therapy Association for three years. Awareness of how people live and move in their bodies has always been an aspect of Rachel’s approach to psychotherapy.
During the mid-eighties into the early aughts, Rachel led workshops at Omega Institute, NY and Esalen Institute, CA. She wrote Twenty Minute Retreats: Revive Your Spirit in Just Minutes a Day with Simple, Self-Led Practices (NY: Holt, 2000). This book describes many of the psychological, meditative and body awareness exercises she taught in her workshops.
In 2005 Rachel traveled to a retreat center in Costa Rica and serendipitously found herself with the opportunity to drink ayahuasca with Ecuadorian shamans. The morning after her first ceremony, Rachel began asking questions about the therapeutic potential of this medicine. She conducted a three-year research project with Lee Gurel, PhD that resulted in “A Study of Ayahuasca Use in North America,” published in the Journal of Psychoactive Drugs (Summer, 2012).
Rachel has a married daughter, Ashley Mason, who sings in the chorus at the Metropolitan Opera in NYC. Rachel is the co-author with Dorothy Nolte of Children Learn What They Live and Teenagers Learn What They Live (NY: Workman, 1998 and 2002) and the author of 20 Minute Retreats (Holt, 2000). Rachel spends eight months of the year on a remote island in Penobscot Bay, ME and winters in Napa, CA.
Current degree program: Master’s in medical anthropology
My master’s thesis investigated the phenomenology of the psychedelic experience in ibogaine treatment for opioid addiction as well as what ibogaine treatment can teach us about the limitations of Western biomedical approaches to conceptualizing and treating addiction. More generally, I am interested in psychedelic research which emphasizes the role of set and setting and seeks to investigate psychedelic medicine in terms of what Schenberg calls “experience efficacy.”
Congrats to Olivia Marcus, who was recently selected for a 2018 SRF Connection Award! Olivia has a master’s in public health degree from Columbia University and is currently in a doctoral program in applied medical anthropology at the University of Connecticut. Her project involves an investigation of Ayahuasca-assisted therapies for mental health in the Peruvian amazon. She is also examining different components of this question through both provider level and patient level experiences and beliefs. We will be following this work as she completes the study and provide updates along the way. Congrats Olivia!
Congrats to Lucia Terpak, who was recently selected for a 2018 SRF Source Award! Lucia has a bachelor’s degree from Wake Forest University and is currently in a master’s program in medical anthropology at the University of Colorado at Denver. Her project involves an investigation of the phenomenology of ibogaine-assisted addiction therapy, examining the role of visions, beliefs and rituals in healing. We will be following this work as she completes the study and provide updates along the way. Congrats Lucia!
Congrats to Gabrielle Agin-Liebes, who was recently selected for a 2018 SRF Connection Award! Gabrielle has a bachelor’s degree from New York University and is currently in a doctoral program in clinical psychology at Palo Alto University. Her project involves work that she is completing along with an investigator from NYU. She is conducting a long-term follow-up examination of outcomes associated with psilocybin-assisted psychotherapy on anxiety and psychosocial distress in cancer patients. We will be following this work as she completes the study and provide updates along the way. Congrats Gabby!
Lauren Padgett is a fundraiser and activist who joined the Source Research Foundation board in 2018. Currently, she’s the full-time Development Officer at the ACLU of the District of Columbia, which protects and advances the civil liberties of Washington, DC’s 700,000 unrepresented citizens. Previously, she was the Development Director at Students for Sensible Drug Policy, a nonprofit organization that mobilizes students across the globe to change harmful and unjust drug policies. Lauren joined the SSDP team in 2014 as the first fundraising hire and was with SSDP through its largest period of growth.
Lauren studied psychology at Northeastern University and spent her early career in Boston counseling and supporting adults and young people living with mental illness. Lauren is passionate about applying a social justice lens to organizational development and believes that fundraising plays a crucial role in fostering community and accountability among organizations and their supporters. She especially enjoys training and mentoring new fundraisers.
Dawn D. Davis is Tribal person belonging to the Shoshone-Bannock Tribes. She holds a master’s degree from the University of Arizona where she researched the conservation and sustainability of peyote, an Indigenous medicine, within its natural habitat. She continues to discuss endangerment levels of peyote and preservation efforts among peyotists. Dawn is currently a PhD student at the University of Idaho studying her first medicine, water, with an emphasis in Law, Management, and Policy. Dawn is married to Dr. Cleve Davis and they live on a microfarm with their two daughters, Lilianna and Isla. She also exercises laughter and practices humor often.
Dr. Mariana M. Cajaiba is a physician trained in Clinical Oncology and Anatomic Pathology who currently holds an appointment as Associate Professor at Northwestern University Feinberg School of Medicine. She has an extensive record of scholarly activity, having participated as a principal or co-investigator in numerous original research projects, and has played a leadership role in the medical community through the development and implementation of clinical protocols and guidelines, participation in scientific review committees, and editorial responsibilities for several peer-review medical journals. As a graduate of the California Institute for Integral Studies Psychedelic-Assisted Therapies and Research Certificate Program, Dr. Cajaiba has a passion for understanding the healing impact of the therapeutic use of psychedelics, and is the first Emeritus member of the Board of Directors at Source Research Foundation.
Dr. Lynnette “Nette” A. Averill is a clinical research psychologist at the National Center for PTSD-Clinical Neurosciences Division (NCPTSD-CND) at the VA Connecticut and Yale School of Medicine Department of Psychiatry. She earned her PhD at the University of Utah after completing a clinical internship at the Michael E. DeBakey VA Medical Center in Houston, TX. Her fellowship training emphasized the neurobiology of PTSD and pharmacoimaging trials, focused on the novel, investigational antidepressant ketamine and multi-method magnetic resonance imaging (MRI) and spectroscopy (MRS). In addition to her work with ketamine clinical trials, Dr. Averill is collaborating on an MDMA neuroimaging study and had the opportunity to complete portions of the training in MDMA-assisted psychotherapy for PTSD under the mentorship of Michael and Annie Mithoefer. She is especially interested in novel pharmacologic interventions with potential to provide rapid and robust improvements in symptoms, including chronic PTSD and suicidality.
Dr. Averill has a strong and dedicated history of Veteran-centric research and clinical work within the VA, focused on posttraumatic mental health, neuropsychological assessment, cognitive function, suicidal ideation and behavior, and evidence-based treatments for mood and anxiety disorders. Her father was an enlisted infantryman with the US Marine Corps during the Vietnam War, and, like so many service members, struggled to cope with what he had experienced in theater. He died by suicide when she was three years old. Although she has no memory of him, his life and subsequent death has guided the course of her life, shaping Dr. Averill both personally and professionally. Her commitment to working in this field, serving Veterans, and engaging in research focused on novel treatments for PTSD and suicidality is evidenced by continual research and clinical practice throughout graduate school, internship, and fellowship, in addition to her Fulbright work (at the Australian Centre for Posttraumatic Mental Health), and now her junior faculty position at the NCPTSD-CND and Yale. She began working at the Salt Lake City VA in May 2004, while still an undergraduate student. She has worked consistently, never straying from this path, and with experience and advancing doctoral education, has progressed from making photocopies and sharpening pencils for the PTSD Clinic, to providing a wide range of clinical services, engaging in stress and trauma-centric research, and being awarded the Utah Campus Compact Outstanding Student Humanitarian Award for her dedication to Veterans’ Mental Health and service to the VA, being actively engaged in leadership roles in relevant international professional organizations (ISTSS, INS), serving as a contributing editor for Clinician’s Trauma Update – Online and Traumatic StressPoints, being selected for travel awards to some of the field’s premier professional organizations (ACNP, ISCTM), serving as Managing Editor for a new scientific journal Chronic Stress (published by Sage), leading and co-authoring numerous original and review manuscripts published in peer-reviewed journals, securing competitive funding including VA, American Foundation for Suicide Prevention, and the Brain and Behavior Foundation/NARSAD, and now having the opportunity serve as an inaugural member of the Board of Directors and Chair of the ARC for Source Research Foundation.
Dr. Brooke J. Arterberry is currently an Assistant Professor in the Department of Psychology at Iowa State University. Dr. Arterberry completed her Postdoctoral Training at the University of Michigan Addiction Center in the Department of Psychiatry and the Ann Arbor VA. She received her Ph.D. in Counseling Psychology at the University of Missouri, M.S. in Counseling and Counselor Education at Indiana University, and B.A. in Psychology and English at the University of Southern Indiana. Her research focuses on understanding the developmental risks associated with substance use (e.g., alcohol and cannabis use/co-use) using a socio-ecological perspective and polysubstance use framework. She is also interested in the development of efficacious intervention/prevention programs aimed at reducing adolescent and young adult substance use behaviors that result in negative consequences. Because of her training experiences, Dr. Arterberry believes mentorship and supporting students in opportunities to pursue their research passions will aid in understanding the differences in recreational and medicinal uses of substances – especially within the burgeoning area of psychedelic research.